Clinical Trials in Austin

Showing 8781-8800 of 15,205 trials

Sebacia Postmarket Study of Real-World Use

NCT03818555

Postmarket study of Sebacia Microparticles treatment during adoption into clinical use for patients with mild to moderate inflammatory acne vulgaris.

Acne Vulgaris

Sebacia, Inc.125 participantsStarted Jan 2019

Miami, Florida, United States • Boston, Massachusetts, United States • Murfreesboro, Tennessee, United States +3 more locations

COMPLETEDNA< 1 mile

A Clinical Study to Assess the Effect of Novel Glycans on Nitrogen Metabolism of the Gut in Healthy Subjects

NCT04603378

This exploratory, randomized, double-blind, placebo-controlled study aims to explore the effect of novel glycans on nitrogen metabolism in the gut in healthy subjects using a stable isotope.

Healthy

Kaleido Biosciences47 participantsStarted Sep 2017

Austin, Texas, United States

COMPLETEDPhase 2< 1 mile

A Study to Assess Safety and Efficacy of KarXT in Adult Patients With Schizophrenia

NCT03697252

This is a Phase 2, randomized, double-blinded, placebo-controlled, inpatient study to examine the efficacy, safety, and tolerability profile of KarXT in adult subjects diagnosed with DSM-5 schizophrenia who are in an acute exacerbation phase. The primary objective of the study is to assess the efficacy of KarXT (a fixed combination of xanomeline and trospium chloride) (xanomeline 125 mg/trospium 30 mg twice daily \[BID\]) versus placebo in reducing Positive and Negative Syndrome Scale (PANSS) total scores in adult inpatients with a Diagnostic and Statistical Manual-Fifth Edition (DSM-5) diagnosis of schizophrenia. The secondary objectives of the study are to assess overall safety and tolerability of KarXT in adult inpatients with a DSM-5 diagnosis of schizophrenia.

Schizophrenia

Karuna Therapeutics, Inc., a Bristol Myers Squibb company182 participantsStarted Sep 2018

Little Rock, Arkansas, United States • Lemon Grove, California, United States • Long Beach, California, United States +9 more locations

Sebacia Postmarket Study of Real-World Use

A Clinical Study to Assess the Effect of Novel Glycans on Nitrogen Metabolism of the Gut in Healthy Subjects

A Study to Assess Safety and Efficacy of KarXT in Adult Patients With Schizophrenia

Find Trials by Condition in Austin

Study of Intravitreal REGN2176-3 in Participants With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)

Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches

Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Abdominoplasty

Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases

Study to Assess Safety and Efficacy of Filgotinib, Lanraplenib and Tirabrutinib in Adults With Active Sjogren's Syndrome

The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias

Topical Rapamycin to Erase Angiofibromas in TSC

A Bioequivalence Study With Clinical Endpoints to Evaluate the Safety and Therapeutic Equivalence of Permethrin Cream 5% & Elimite™ in Subjects With Scabies

Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer

Randomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy

A Phase 2, Study of Ficlatuzumab Plus Erlotinib vs. Placebo Plus Erlotinib in Subjects With Previously Untreated Metastatic, EGFR-mutated NSCLC and BDX004 Positive Label

Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma

Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas

Type 1 Diabetes and the Brain in Children

Study to Evaluate the Safety and Effectiveness of the CODMAN ENTERPRISE® Vascular Reconstruction Device

Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study

Exploratory Study of Relationships Between Malodor and Urine Metabolomics